Seattle Project Corporation
1 clinical trials · Sponsor
◉ Watch Seattle Project Corporation
| Record | Firm | Date |
|---|---|---|
| A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer (NCT05141721) | Seattle Project Corporation | 2022-02-12 |
Track Seattle Project Corporation automatically
Every clearance here is in the API, with alerts when new ones post.